News Briefs

November 4

✦ CMS on Nov. 2 finalized changes intended to boost participation in the Medicare Diabetes Prevention Program (MDPP) expanded model. In the Calendar Year 2022 Physician Fee Schedule final rule, CMS finalized proposals to waive the Medicare enrollment fee for MDPP suppliers beyond the end of the public health emergency, shorten the program services period to one year by eliminating the second year of maintenance sessions, and redistribute all of the Ongoing Maintenance sessions phase performance payments to certain Core and Core Maintenance Session performance payments.

0 Comments

RADAR on Medicare Advantage

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Datapoint: Jefferson Health Completes Health Partners Plans Deal November 4, 2021

Select Insurers Enhance Grocery Allowances, Nutrition Benefits for Duals Next Year November 4, 2021

https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured_AdobeStock_274078056.jpg

November 18

Medicare Advantage Insurers Step Up SNP Offerings for 2022, Particularly for Duals

https://www.mmitnetwork.com/wp-content/uploads/2021/09/MCO-Stock-Performance-August-2021.jpg

November 18

Given COVID Surge, Humana Deviates From Peers With Lower Guidance

https://www.mmitnetwork.com/wp-content/uploads/2021/09/WordPress-Featured-Image-radar-on-medicare-advantage-MedPAC-Reforms-to-Part-D-LIS-Could-Produce-Savings.jpg

November 18

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

News Briefs

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Related Posts

Medicare Advantage Insurers Step Up SNP Offerings for 2022, Particularly for Duals

Given COVID Surge, Humana Deviates From Peers With Lower Guidance

Clover Health Struggles to Contain Medical Costs for MA Members

The Latest

Premium Categories

Meet Our Reporters

Jill Brown Kettler Executive Editor

Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits

Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits

Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access

Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits

Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Tags

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND